Free Newsletter
What's next for Genentech employees?
Imagine you're a Genentech worker in San Diego. Since Roche and Genentech first signed their partnership deal in the 1990s, you've enjoyed a relatively hands-off approach that's allowed independent research to thrive. In fact, Roche's affiliation with Genentech is regarded as the gold standard of what a Big Pharma's relationship with a small biotech should be. Article
Comments
What's next? Many of us are going to take our retention bonus and vested shares and exit the back as Roche comes in the front. They (Roche) are so foolish and arrogant. I just can't bring myself to work for a company that is prepared to unravel something so awesome. I don't understand Roche thinks this is going to work out? We utterly hate them!!!
at least roche people are smart - unlike the idiots at GNE.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





